Penumbra, Inc.

PENNYSEUSD
322.32 USD
0.65 (0.20%)AT CLOSE (11:59 AM EDT)
322.31
0.02 (0.00%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
322.31
0.02 (0.00%)
🔴Market: CLOSED
Open?$323.19
High?$324.12
Low?$321.45
Prev. Close?$322.97
Volume?443.7K
Avg. Volume?477.2K
VWAP?$322.87
Rel. Volume?0.93x
Bid / Ask
Bid?$297.52 × 40
Ask?$350.00 × 40
Spread?$52.48
Midpoint?$323.76
Valuation & Ratios
Market Cap?12.7B
Shares Out?39.3M
Float?38.0M
Float %?96.9%
P/E Ratio?74.12
P/B Ratio?8.60
EPS?$4.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Employees
4.7K
Market Cap
12.7B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2015-09-18
Address
ONE PENUMBRA PLACE
ALAMEDA, CA 94502
Phone: (510) 995-2486
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.02Strong
Quick Ratio?3.95Strong
Cash Ratio?1.14Strong
Debt/Equity?0.02Low
ValuationRICHLY VALUED
Score
33/100
P/E?
74.1PRICEY
P/B?
8.60HIGH
P/S?
8.72HIGH
P/FCF?
59.6PRICEY
EV/EBITDA?
61.0HIGH
EV/Sales?
8.57HIGH
Returns & Efficiency
ROE?
11.6%FAIR
ROA?
9.0%STRONG
Cash Flow & Enterprise
FCF?$212.7M
Enterprise Value?$12.5B
Fundamentals ratios updated end of day